Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-175-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Reproductive toxicity
One-generation
The reproductive and developmental NOEL was 250 ppm in rats (OECD TG 415)
Additional information
Potential effects of the test material on fertility were evaluated in a one generation reproduction study in rats. There were no treatment-related effects on estrus cycling at any dietary concentration up to and including 1500 ppm as determined by number of estrus stages during the evaluation period or mean cycle length. There were no treatment-related effects on sperm motility, morphology, epididymal sperm count or concentration, testicular sperm count and concentration at any dietary level up to and including 1500 ppm.
Additionally, in a 4-week repeated-exposure inhalation toxicity study testicular weights and testicular as well as uterine histopathology was not altered following exposure to the test material. In 4-week repeated-exposure dermal toxicity study testicular weight and histopathology was not altered following exposure to the test material.
Short description of key information:
Reproductive toxicity
One-generation
The reproductive and developmental NOEL was 250 ppm in rats (OECD TG 415)
BMDL10 511 ppm
Effects on developmental toxicity
Description of key information
Developmental toxicity/teratogenicity
The NOAEL for teratogenicity 45 mg/kg in rats (OECD TG 414)
Effect on developmental toxicity: via dermal route
- Dose descriptor:
- NOAEL
- 45 mg/kg bw/day
Additional information
Presumed pregnant Crl:CD®(SD)IGS BR VAF/Plus® rats were exposed to solutions of the test substance in Neutral Oil 100 N administered percutaneously once daily on days 6 through 20 of presumed gestation (DGs 6 through 20) at dosages of 0 (Vehicle), 5, 15 and 45 mg/kg/day. No fetal gross external, soft tissue or skeletal alterations (malformations or variations) were caused by dosages of the test substance as high as 45 mg/kg/day. The maternal no-observed-adverse-effect-level is 5 mg/kg/day. Adverse clinical observations, skin reactions and reductions in body weights and feed consumption were observed in the 15 and/or 45 mg/kg/day dose groups. An increase in the number of rats sacrificed for humane reasons was observed in the 45mg/kg/day dose group. No developmental effects were seen at any doses that were related to treatment with test material. The developmental NOEL is 45 mg/kg/day.
Toxicity to reproduction: other studies
Additional information
This study was performed to investigate the effects of the test material on growth, development and reproductive performance in male and female rats through one generation. The test material was administered in the diet at concentrations of 0, 250, 750 or 1500 ppm. These dietary concentrations resulted in consumed doses of 0, 19.1, 55.6, and 107.3 mg/kg/day respectively in males during premating and 21.0, 62.8, and 124.1 mg/kg/day respectively in females during premating. Continuous exposure of rats to test material in the diet through one generation had a No Observed Effect Level (NOEL) for parental animal toxicity of 250 ppm [19.1 mg/kg/day in males; 21.0 mg/kg/day in females]. The reproductive and developmental NOEL was 250 ppm due to decreased pup body weights at both 750 and 1500 ppm and delayed sexual maturation in females at 750 ppm and in both sexes at 1500 ppm. Detailed evaluation of the study data revealed a clear weight of evidence to support the conclusion that the delays in puberty onset by the test material are due to decrements in pup body weight secondary to maternal toxicity.
Justification for classification or non-classification
No developmental effects were seen at any doses that were related to treatment with the test material in a percutaneous pre-natal developmental study.
The test material is not classified as a reproductive toxicant. Detailed evaluation of the study data revealed a clear weight of evidence to support the conclusion that delays in puberty onset by the test material are due to decrements in pup body weight secondary to maternal toxicity and therefore do not warrant reproductive or developmental classification.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2